A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT06215755 · TERMINATED

Trial details

NCT number: NCT06215755
Sponsor: Verge Genomics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2024-01-15
Primary completion: 2025-07-07
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.